Panacea Life Sciences Holdings, Inc. (PLSH) Gross margin 2019–2023
Panacea Life Sciences Holdings, Inc. (PLSH) gross margin by fiscal year — reported gross profit divided by reported revenue.
47.0%FY2023 · since FY2019: -491.9% → 47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 47.0% | +22.7 pp |
| FY2022 | 24.4% | -1.9 pp |
| FY2021 | 26.2% | +4.1 pp |
| FY2020 | 22.2% | +514.1 pp |
| FY2019 | -491.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice